CTOs on the Move

Deciphera

www.deciphera.com

 
Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company focused on improving the lives of cancer patients by tackling key mechanisms of drug resistance that limit the effectiveness of many cancer therapies. Our small molecule drug candidates are directed against an important family of enzymes called kinases, known to be directly involved in the growth and spread of many cancers. We use our deep understanding of kinase biology together with a proprietary chemistry library to purposefully design compounds that maintain kinases in a “switched off” or inactivated conformation. Deciphera has developed a diverse pipeline of drug candidates designed to improve outcomes for ...
  • Number of Employees: 100-250
  • Annual Revenue: $500M-1 Billion
  • www.deciphera.com
  • 500 Totten Pond Road 6th Floor
    Waltham, MA USA 02451
  • Phone: 781.209.6400

Executives

Name Title Contact Details
Senthil Gopal
 Director of Cyber Security Profile
Elizabeth Ruhl
 Senior Director, IT Governance, Risk, and Compliance - Information Security Profile
Stephen Aschettino
 Vice President and Chief Information Officer Profile
Stephen Ruddy
 Chief Technical Officer Profile

Similar Companies

CuraScript

CuraScript is one of the nation's largest providers of specialty injectable and oral medications. CuraScript has been in the specialty pharmacy business since 1989. Between 1994 and August 1, 2000, the company operated as Coram Prescription Services

Children's Crisis Treatment Center

CCTC passionately serves the emotional needs of children and families at risk beginning in early childhood.

EMR Innovations

EMR Innovations is a Saint Cloud, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

AandA Phamachem

A&A Phamachem Inc. is a Nepean, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Curie Therapeutics

Curie Therapeutics is a fully integrated, next-generation radiopharmaceuticals company focused on pioneering a new class of targeted radiopharmaceuticals that are both safe and effective. Curie`s radiopharmaceuticals are composed of rationally designed conjugates against carefully selected biological targets, to deliver alpha and beta-emitting radionuclide payloads. Curie`s mission is to revolutionize the use of radiomedicines in cancer.